Privilège Ventures

VC Lugano, Switzerland · Founded 2021

Privilu00e8ge Ventures is a FINMA-authorized Swiss venture capital firm investing in early-stage European startups across HealthTech, CleanTech, and AgriFoodTech, with a strong emphasis on backing diverse, gender-mixed, and female-led founding teams.

About Privilège Ventures

Privilège Ventures is a Switzerland-based venture firm with a stated focus on backing female founders and diverse teams across European technology companies, with website, LinkedIn and Crunchbase presence. The firm typically invests at seed and Series A across enterprise software, consumer technology, fintech, healthcare technology and adjacent sectors, with thesis-driven attention to founder diversity. Plausible check sizes sit in the EUR 250K to EUR 1.5M range as a participant in seed rounds, with selective capacity to lead small rounds and modest reserves for follow-on. Geographic focus is Switzerland and broader Europe. For healthcare founders, Privilège is most relevant if you have at least one female founder or a diverse founding team and are building a digital health, healthcare technology or healthcare-adjacent SaaS business with European operations or distribution. The firm is a poor fit for US-only founders, all-male founding teams that don’t fit the diversity thesis, and capital-intensive therapeutics, devices and diagnostics requiring sector-specialist diligence depth. Founders should expect commercial-led diligence with emphasis on team, market sizing, traction and capital efficiency, and should view the firm as a thesis-aligned syndicate participant rather than a healthcare specialist. Entry is best via warm introductions from European female-founder networks, Swiss ecosystem connectors, or fellow seed-stage co-investors; LinkedIn outreach to investment principals is workable. Founders should clarify fund size, current deployment pace, healthcare exposure in the existing portfolio and lead capacity in any first conversation before investing significant cycles.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Privilège Ventures

Tools made by companies in Privilège Ventures's portfolio that we cover in the directory.

Leal Health (formerly Trialjectory)
Leal Health
Drug Discovery & Research
An AI-powered decision-support platform that matches cancer patients with relevant clinical trials, assisting oncologists in finding personalized treatment options.

Portfolio companies in our directory

Other portfolio companies

Companies in Privilège Ventures's portfolio not currently in our directory.

Team

Jacqueline Ruedin Ru00fcsch
Founding General Partner
LinkedIn
Angelica Morrone
General Partner
LinkedIn

Pitch / review this investor

Have you raised from Privilège Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.